Literature DB >> 18625161

Advances in the understanding of eclampsia.

S Ananth Karumanchi1, Marshall D Lindheimer.   

Abstract

Preeclampsia, a serious hypertensive complication of pregnancy characterized by new-onset hypertension and proteinuria after midpregnancy, is a multisystem disorder that often involves the central nervous system. Neurologic signs and symptoms include hyperreflexia, headaches, visual disturbance, seizures, and cerebral hemorrhage. Eclampsia-new-onset seizures in the setting of preeclampsia-usually occurs before or within 48 hours of delivery, but can present as late as 1 month postpartum (late postpartum eclampsia). Magnesium sulfate is the drug of choice to prevent and treat eclampsia, a recommendation validated through large, randomized, and placebo-controlled trials. This review describes the pathogenesis, clinical features, and treatment of eclampsia, focusing on recent observations regarding roles of circulating antiangiogenic factors in the pathogenesis of the neurologic complications of eclampsia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18625161     DOI: 10.1007/s11906-008-0057-3

Source DB:  PubMed          Journal:  Curr Hypertens Rep        ISSN: 1522-6417            Impact factor:   4.592


  48 in total

1.  Discriminatory proteomic biomarker analysis identifies free hemoglobin in the cerebrospinal fluid of women with severe preeclampsia.

Authors:  Errol R Norwitz; Lawrence C Tsen; Joong Shin Park; Patricia A Fitzpatrick; David M Dorfman; George R Saade; Catalin S Buhimschi; Irina A Buhimschi
Journal:  Am J Obstet Gynecol       Date:  2005-09       Impact factor: 8.661

Review 2.  Bevacizumab in the treatment of metastatic colorectal cancer: safety profile and management of adverse events.

Authors:  Herbert Hurwitz; Shermini Saini
Journal:  Semin Oncol       Date:  2006-10       Impact factor: 4.929

Review 3.  Diagnosis, prevention, and management of eclampsia.

Authors:  Baha M Sibai
Journal:  Obstet Gynecol       Date:  2005-02       Impact factor: 7.661

4.  Persistence of cerebral hemodynamic changes in patients with eclampsia: A report of three cases.

Authors:  K P Williams; S Wilson
Journal:  Am J Obstet Gynecol       Date:  1999-11       Impact factor: 8.661

Review 5.  Cerebral hemodynamics in preeclampsia and eclampsia.

Authors:  A I Qureshi; M R Frankel; J R Ottenlips; B J Stern
Journal:  Arch Neurol       Date:  1996-12

6.  Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial.

Authors:  Douglas Altman; Guillermo Carroli; Lelia Duley; Barbara Farrell; Jack Moodley; James Neilson; David Smith
Journal:  Lancet       Date:  2002-06-01       Impact factor: 79.321

7.  Eclampsia: a neurological perspective.

Authors:  A K Shah; K Rajamani; J E Whitty
Journal:  J Neurol Sci       Date:  2008-05-20       Impact factor: 3.181

8.  Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987-2004.

Authors:  Anne B Wallis; Audrey F Saftlas; Jason Hsia; Hani K Atrash
Journal:  Am J Hypertens       Date:  2008-03-13       Impact factor: 2.689

9.  Delayed postpartum preeclampsia: an experience of 151 cases.

Authors:  Laura A Matthys; Kristin H Coppage; Donna S Lambers; John R Barton; Baha M Sibai
Journal:  Am J Obstet Gynecol       Date:  2004-05       Impact factor: 8.661

10.  VEGF and TGF-beta are required for the maintenance of the choroid plexus and ependyma.

Authors:  Arindel S R Maharaj; Tony E Walshe; Magali Saint-Geniez; Shivalingappa Venkatesha; Angel E Maldonado; Nathan C Himes; Kabir S Matharu; S Ananth Karumanchi; Patricia A D'Amore
Journal:  J Exp Med       Date:  2008-02-11       Impact factor: 14.307

View more
  15 in total

1.  Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells.

Authors:  A Rajakumar; T Chu; D E Handley; K D Bunce; B Burke; C A Hubel; A Jeyabalan; D G Peters
Journal:  Placenta       Date:  2010-11-13       Impact factor: 3.481

Review 2.  Pathogenesis and treatment of bronchopulmonary dysplasia.

Authors:  Jason Gien; John P Kinsella
Journal:  Curr Opin Pediatr       Date:  2011-06       Impact factor: 2.856

3.  Effects of maternal serum on permeability of glomerular endothelial cell membrane.

Authors:  Hui Du; Haiyi Liu; Jun Zhao; Yuanyuan Wu; Xun Gong; Qiong Zhou; Jingjing Xu; Yuqi Li; Xinwei Shi; Fuyuan Qiao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-02-19

4.  Placental Nkx2-5 and target gene expression in early-onset and severe preeclampsia.

Authors:  Elena R Rivers; Anthony J Horton; Angela F Hawk; Elizabeth G Favre; Katherine M Senf; Paul J Nietert; Eugene Y Chang; Ann C Foley; Christopher J Robinson; Kyu-Ho Lee
Journal:  Hypertens Pregnancy       Date:  2014-07-02       Impact factor: 2.108

Review 5.  Mechanotransduction and Uterine Blood Flow in Preeclampsia: The Role of Mechanosensing Piezo 1 Ion Channels.

Authors:  Olufunke O Arishe; Anthony B Ebeigbe; R Clinton Webb
Journal:  Am J Hypertens       Date:  2020-01-01       Impact factor: 2.689

Review 6.  The diagnosis and treatment of hypertensive disorders of pregnancy: new findings for antenatal and inpatient care.

Authors:  Werner Rath; Thorsten Fischer
Journal:  Dtsch Arztebl Int       Date:  2009-11-06       Impact factor: 5.594

7.  The adaptation of the blood-brain barrier to vascular endothelial growth factor and placental growth factor during pregnancy.

Authors:  Malou P H Schreurs; Emily M Houston; Victor May; Marilyn J Cipolla
Journal:  FASEB J       Date:  2011-09-12       Impact factor: 5.191

Review 8.  Bronchopulmonary dysplasia: Pathogenesis and treatment.

Authors:  Asfia Banu Pasha; Xiao-Qing Chen; Guo-Ping Zhou
Journal:  Exp Ther Med       Date:  2018-09-19       Impact factor: 2.447

9.  Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling.

Authors:  Odül A Amburgey; Abbie C Chapman; Victor May; Ira M Bernstein; Marilyn J Cipolla
Journal:  Hypertension       Date:  2010-09-20       Impact factor: 10.190

10.  Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.

Authors:  Irina E Zazerskaya; Valentina V Ishkaraeva; Elena V Frolova; Nelly G Solodovnikova; Yulia N Grigorova; C David Adair; Olga V Fedorova; Alexei Y Bagrov
Journal:  Am J Hypertens       Date:  2013-07-22       Impact factor: 2.689

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.